*By Christian Smith* Bud might seem like the new brew, with so many beer companies [investing in cannabis](https://cheddar.com/videos/corona-brewer-adds-cannabis-to-its-booze-business-in-4-billion-deal) and making THC-infused beverages. But Heineken's future, like its long history, lies in beer. "We believe that core growth still remains in the beer category itself," Jonnie Cahill, Heineken USA's chief marketing officer said in an interview with Cheddar. "For sure there will be some overlap between the categories, but we know over time beer is a staple of young people and everybody's life." Constellation, the company behind Corona and Modelo, announced a $4 billion investment Wednesday in the Canadian cannabis company Canopy Growth. The news excited consumers, but caused a sell-off in Constellation's stock over concerns the beverage conglomerate paid too much for a 38 percent stake in a company valued around $5 billion. Heineken has its own entrant in the cannabis-beer crossover market. The company has a 50 percent stake in Lagunitas, which launched in June its first cannabis-infused drink, HiFi Hops. It's an alcohol-free beverage that tastes like beer but with the high-flying effects of THC. No matter the products, Cahill said, Heineken's strategy for reaching new customers remains the same. "It's about making people smile, improving their weekends, bringing people together, and socializing." For full interview, [click here] (https://cms.cheddar.com/videos/VmlkZW8tMjIyMTQ=).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More